Xiamen Amoytop Biotech (688278.SH) announced on June 14th that Director Lan Chun plans to reduce his holding of company stocks by no more than 380,000 shares, which is less than 0.093% of the total share capital of the company, due to personal fund requirements, by means of centralized bidding and bulk trading. This accounts for no more than 25% of his current holdings of the company's shares. During the period of reduction, the price will be determined based on the market price during the implementation period. The reduction period will start from 15 trading days after the disclosure of this announcement and end 3 months later.
特宝生物(688278.SH)：董事兰春拟合计减持不超过38万股的公司股份
Xiamen Amoytop Biotech (688278.SH): Director Lan Chun plans to reduce a total of no more than 380,000 shares of the company's shareholding.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.